PREPARATION AND CHARACTERIZATION OF CO-CRYSTALS OF DIACEREIN
Diacerein, anti-inflammatory drug used in the treatment of osteoarthritis. Being a BCS class II drug, it has poor solubility, dissolution rate and other physicochemical properties. Thus the aim of present study was to prepare co-crystals of diacerein to improve solubility, dissolution rate. The diacerein co-crystals were prepared using urea and tartaric acid as conformer by Solvent drop grinding method. The diacerein co-crystals were characterized by scanning electron microscopy (SEM), FT-IR spectroscopy (FT-IR), Differential scanning calorimetry (DSC) and X-ray diffractometry (XRD). The co-crystals were evaluated for solubility, dissolution rate and other physicochemical properties and compared with commercial diacern sample. The co-crystals exhibit the difference in the size and shape of crystals. The FT-IR spectra of diacerein co-crystals showed slightly different in the characteristic peaks compared to commercial diacerein sample. DSC data indicate the decrease in the melting endotherm of co-crystals compare to diacerein. The co-crystals with urea showed increase and intense peak and co-crystals with tartaric acid showed decreased number of peaks compared to commercial diacerein. The co-crystals of diacerein formulated in to the Tablet and evaluated for tablet properties. The tablet formulation showed improved tablet characteristics as well as dissolution rate compared to commercial diacerein.
Full Text:PDF (34-41)
Anindita S., Sohrab R., 2014,Co-crystals of Acyclovir with promising physicochemical properties, J. Pharma. Sci, Vol-104, Issue-1, pp.98-105.
Deshmukh DB. et al,. 2010, Dissolution Enhancement of Poorly Water Soluble Diacerein By Solid Dispersion Technique. J. Pharm. Sci. Res. 2:734-739.
Gagniere E., Margin D., Puel P., Rivoire A., Monnier O. 2009, Formation of co-crystal kinetic and thermodynamic aspects. J.Crystal Growth;11: 2689-2695.
Harry G., Brittain. 2006, Polymorph in Pharmaceutical solids. Mercel Dekker publication,7:1-2.
Hickey M., Peterson M., Scoppettuolo L., Morrisette S. 2007; Performance com-parison of co-crystal of Carbamazepine with marketed product, Eur. J Pharm. Biopharm., 67: 112-119.
Lachman L., Lieberman H., 1991, The theory and practice of Industrial Pharmacy. Third Editon; Varghese publishing house, 3:180.
Mahajan A., Singh K., Tandon VR., 2006, Diacerein: A New Symptomatic Slow Acting Drug for Osteoarthritis. JK Sci, 8:173-75.
Maski N., Arul K., 2009, Studies on the preparation, characterization and solubility of Cyclodextrendiacerein complex. Int J Pharm and Sci 1:121-35.
Nanjwade VK., Shulka VK., Manvi FV. 2012, Development and characterization of novel pharmaceutical Crystalline complex of lomefloxacin. Int. J. Drug Dev. Res; 1:227-33.
Saifee M., Inamdar N., Dhamecha D., 2009.; Drug polymorphism review; Int. J. Health research, 2:291-366.
Shital S., Shete AS., Doijad RC., Kadam SS., Patil VA., Yadav AV., 2015, Formulation and Solid State Charac-terization of Nicotinamide-based Co-crystals of Fenofibrate.Ind. Jr. Pharm. Sci. 77(3), pp-328-334.
Subhrahmanyam CVS., Thima SA., Devi SK., 2000, Pharmaceutical engineering principle and practices. Vallabhprakashan,: pp-42.
Vippagunta SR., Brittan H., Grant G. 2001, Crystalline solids Advanced drug Delivery reviews, pp 48: 3-26.
Yadav DS., 2012, Preparation and characteri-zation of Diacerein microcrystall. Der Pharmacia Lettre, 4:428-435.
Zhou Z., Li W., Sun W-z., 2016, Resveratrol cocrystals with enhanced solubility and tabletability, J. Pharma. Sci, Vol-509, Issue-1-2, pp.391--399.
- There are currently no refbacks.
Copyright (c) 2017 INDONESIAN JOURNAL OF PHARMACY
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Indonesian J Pharm indexed by:
View My Stats